Experts publish a review of lung cancer treatments for patients with COVID-19
Lung cancer patients are at heightened risk for COVID-19 and the reported high mortality rate among lung cancer patients with COVID-19 has given pause to oncologists who are faced with patients with not one, but two severe, life-threatening diseases.
No hay comentarios:
Publicar un comentario